Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. -2.62%23.466.3%$1308.68m
TMOThermo Fisher Scientific, Inc. 1.72%386.771.0%$577.73m
MDTMedtronic Plc -0.04%91.630.6%$539.89m
DXCMDexCom, Inc. 2.17%435.118.2%$530.92m
BDXBecton, Dickinson & Co. 0.51%252.651.0%$511.29m
ABTAbbott Laboratories 0.13%92.580.8%$506.36m
DHRDanaher Corp. 1.30%184.410.7%$453.05m
BSXBoston Scientific Corp. -0.29%34.541.1%$428.78m
QDELQuidel Corp. 5.56%237.487.7%$402.17m
ISRGIntuitive Surgical, Inc. 0.98%580.962.4%$343.32m
SYKStryker Corp. 0.85%181.871.3%$315.38m
BAXBaxter International, Inc. -1.57%84.161.8%$276.48m
ALGNAlign Technology, Inc. 1.34%278.396.4%$244.82m
ZBHZimmer Biomet Holdings, Inc. 1.62%118.891.7%$211.46m
EWEdwards Lifesciences Corp. 0.25%68.740.4%$201.08m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.